CClinicalTrials.gg
CompletedNCT02597192Updated Nov 5, 2015

Clinical Effects of Bacillus Containing Oral Hygiene Products on Gingivitis: a Randomized Controlled Trial

An interventional study of probiotic oral hygiene products with Bacillus (PIP, Chrisal) and oral hygiene products without Bacillus in Gingivitis, sponsored by Cukurova University. Completed at 1 site in Turkey. Open to participants aged 18 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2015-11-05.

Sponsored by Cukurova University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
All
01

Study summary

Aim: Evaluating the clinical effects of a Bacillus subtilis, Bacillus megaterium and Bacillus pumulus containing toothpaste, mouthwash and toothbrush cleaner versus a placebo in patients with generalized gingivitis.

Materials and methods: In this double-blind placebo-controlled randomized clinical trial generalized gingivitis patients who were systemically healthy and who did not smoke were included. They used a placebo or probiotic Bacillus containing toothbrush cleaner for 8 weeks. Primary outcome measures of interest were plaque and gingivitis index, secondary outcome measures were pocket probing depth and bleeding on probing.

Read the detailed description

The administration of micro-organisms to improve the human health was already promoted by the Nobel prizewinning scientist Eli Metchnikoff in the beginning of the 20th century. However, it took several decades for this subject to become a topic of interest in medicine. At this moment these micro-organisms are called "probiotics" and defined as "living microorganisms which, when administered in adequate amounts, confer a health benefit for the host" (http://www.who.int/foodsafety/publications/fs_management/en/probiotics.pdf). Over the past decade probiotics have been extensively investigated from the perspective of oral health. It was shown that probiotics have the capacity to reduce mutans streptococci counts in saliva and/or plaque during their usage, that they have a positive influence on bad breath and that they can improve the results of scaling and root planing in periodontitis patients. A positive effect of probiotic usage on plaque accumulation and gingivitis measurements in gingivitis patients was also shown.To the investigators knowledge, at this moment no trials are available describing the effect of other probiotic genera on gingivitis. Since it is clear that probiotic effects are strain, dosage and mode of application dependent, the aim of this study was to evaluate the use of a probiotic toothpaste, mouthwash and toothbrush cleaner with Bacillus subtilis, Bacillus megaterium, and Bacillus pumulus versus a placebo in patients with generalized gingivitis.

02

Conditions studied

  • Gingivitis

Browse trials for

Keywords

  • gingivitis
  • gingival inflammation
  • probiotics
  • Bacillus
03

In context

Gingivitis

590 studies on the registry are indexed under Gingivitis; 105 are open to participants now.

This study's enrollment of 40 is below the median of 64 across 478 interventional studies indexed under Gingivitis.

Browse Gingivitis studies →

Lead sponsor

Cukurova University is the lead sponsor of 247 studies on the registry; 50 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • diagnosed with plaque-induced gingivitis
  • a pocket probing depth not more than 5 mm
  • at least 20 natural teeth
  • no history of periodontal therapy or previous use of antibiotics or anti-inflammatory medication within the preceding 6 months

Exclusion criteria

Exclusion Criteria:

  • patients with hematologic disorders, or other systemic illness
  • pregnant and lactating females
  • patients undergoing orthodontic treatment
  • those with smoking habits were excluded.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
40 participants (actual)

Study arms

  • Active comparator
    Active test group

    probiotic oral hygiene products with Bacillus (PIP, Chrisal)

    Other: probiotic oral hygiene products with Bacillus (PIP, Chrisal)

  • Placebo comparator
    Placebo group

    oral hygiene products without Bacillus

    Other: oral hygiene products without Bacillus

Interventions

  • Otherprobiotic oral hygiene products with Bacillus (PIP, Chrisal)

    products with Bacillus probiotics

  • Otheroral hygiene products without Bacillus

    products without Bacillus

06

What researchers measure

Primary outcomes

  1. gingival index scores

    Time frame: 8weeks

Secondary outcomes

  1. plaque index scores

    Time frame: 8weeks

07

Study locations

1 site
  • Cukurova University
    Adana, 01330, Turkey
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 5, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02597192
Lead sponsor
Cukurova University
Responsible party
Onur Ozcelik (Professor, Cukurova University) — Principal investigator
First posted
Nov 5, 2015
Start date
Jun 2014
Primary completion
Dec 2014
Completion
Oct 2015
Last update
Nov 5, 2015

Study contacts

Onur Ozcelik, Professor
principal investigator · Cukurova University

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion